Kazumasa Miyawaki
Amgen (United States)(US)
Publications by Year
Research Areas
Pancreatic function and diabetes, Diabetes Treatment and Management, Regulation of Appetite and Obesity, Diabetes Management and Research, Diabetes and associated disorders
Most-Cited Works
- → Inhibition of gastric inhibitory polypeptide signaling prevents obesity(2002)943 cited
- → Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice(1999)453 cited
- → Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells(2005)261 cited
- → Antioxidant α‐tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes(2000)126 cited
- → Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis(2003)123 cited
- → Hepatocyte Nuclear Factor-1α Recruits the Transcriptional Co-Activator p300 on the GLUT2 Gene Promoter(2002)96 cited
- → A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1(2013)91 cited
- → Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action(2005)76 cited
- → Inhibition of GIP signaling modulates adiponectin levels under high-fat diet in mice(2008)68 cited
- → Pancreatic and Extrapancreatic Effects of Gastric Inhibitory Polypeptide(2006)56 cited